Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: The ROSE acute heart failure randomized trial

Horng H. Chen, Kevin J. Anstrom, Michael M. Givertz, Lynne W. Stevenson, Marc J. Semigran, Steven R. Goldsmith, Bradley A. Bart, David A. Bull, Josef Stehlik, Martin M. LeWinter, Marvin A. Konstam, Gordon S. Huggins, Jean L. Rouleau, Eileen O'Meara, W. H.Wilson Tang, Randall C. Starling, Javed Butler, Anita Deswal, G. Michael Felker, Christopher M. O'ConnorRaphael E. Bonita, Kenneth B. Margulies, Thomas P. Cappola, Elizabeth O. Ofili, Douglas L. Mann, Victor G. Dávila-Román, Steven E. McNulty, Barry A. Borlaug, Eric J. Velazquez, Kerry L. Lee, Monica R. Shah, Adrian F. Hernandez, Eugene Braunwald, Margaret M. Redfield

Research output: Contribution to journalArticlepeer-review

296 Scopus citations

Fingerprint Dive into the research topics of 'Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: The ROSE acute heart failure randomized trial'. Together they form a unique fingerprint.

Medicine & Life Sciences